Home » Authors » Aaron Lorenzo

Articles by Aaron Lorenzo

Versicor Plans Anidulafungin Esophageal Candidiasis NDA

March 19, 2003

By Aaron Lorenzo

With positive Phase III data in hand, Versicor Inc. reiterated plans to file a new drug application by the end of next month for its lead candidate, anidulafungin. (BioWorld Today)

Versicor Plans Anidulafungin Esophageal Candidiasis NDA

March 19, 2003

By Aaron Lorenzo

With positive Phase III data in hand, Versicor Inc. reiterated plans to file a new drug application by the end of next month for its lead candidate, anidulafungin. (BioWorld Today)

Genta Gains $40M Credit Facility From Late-Stage Partner Aventis

March 18, 2003

By Aaron Lorenzo

Investors Waking Up To Hypnion; Company Closes $47.5M Series B

March 18, 2003

By Aaron Lorenzo

Investors Waking Up To Hypnion; Company Closes $47.5M Series B

March 18, 2003

By Aaron Lorenzo

Genta Gains $40M Credit Facility From Late-Stage Partner Aventis

March 18, 2003

By Aaron Lorenzo

Inspire Increases Share Amount, Raises $67.5M For Eye Products

March 17, 2003

By Aaron Lorenzo

Inspire Increases Share Amount, Raises $67.5M For Eye Products

March 17, 2003

By Aaron Lorenzo

Cytokine PharmaSciences Signs Baxter To MIF Technology Deal

March 14, 2003

By Aaron Lorenzo

Cytokine PharmaSciences Signs Baxter To MIF Technology Deal

March 14, 2003

By Aaron Lorenzo

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 8, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for July 8, 2025.
House passes H.R. 1, restoring R&D tax cuts
BioWorld MedTech
The House of Representatives passed H.R. 1, also known as One Big Beautiful Bill, which will restore personal income tax cuts that expired in 2022. However, the...
Exercise-mimicking compound offers alternative to GLP-1 therapies
BioWorld
An experimental drug for treating diabetes and obesity has been shown to lower blood sugar levels and increase fat burning. It is a β2-adrenergic receptor (β2AR)...
With surface mimicry, molecular glues shed hairpin need
BioWorld Science
Degradation is a therapeutic strategy that could offer possibilities to get at currently undruggable target proteins. In targeted degradation, compounds induce...